Inventor profile of:

Peter Wisdom Atadja

City:

Acton, Massachusetts

Country:

United States

Published Applications:

20

Last publication date:

2018-10-11

Top Assignees for applications by Peter Wisdom Atadja

The entities that hold a legal rights for patent applications filed by inventor Atadja Peter Wisdom:

Recent patent applications by Atadja Peter Wisdom

Peter Wisdom Atadja from Acton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-10-11
US20180289670A1
Human necessities

COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER

#2 | 2018-03-15
US20180071251A1
Human necessities

COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER

#3 | 2017-08-31
US20170246147A1
Human necessities

COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER

#4 | 2017-02-02
US20170027909A1
Human necessities

COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER

#5 | 2016-07-14
US20160199350A1
Human necessities

COMBINATION OF HDAC INHIBITORS WITH THROMBOCYTOPENIA DRUGS

#6 | 2015-04-02
US20150094274A1
Human necessities

COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER

#7 | 2013-07-04
US20130171141A1
Human necessities

COMBINATION OF HDAC INHIBITORS WITH THROMBOCYTOPENIA DRUGS

#8 | 2013-01-31
US20130029927A1
Human necessities

COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER

#9 | 2012-02-02
US20120029047A1
Human necessities

USE OF HDAC INHIBITORS FOR THE TREATMENT OF BONE DESTRUCTION

#10 | 2011-11-24
US20110288144A1
Human necessities

USE OF HDAC INHIBITORS FOR THE TREATMENT OF MELANOMA

#11 | 2011-05-26
US20110124701A1
Human necessities

USE OF HDAC INHIBITORS FOR THE TREATMENT OF LYMPHOMAS

#12 | 2011-05-19
US20110118309A1
Human necessities

USE OF HDAC INHIBITORS FOR THE TREATMENT OF HODGKIN'S DISEASE

#13 | 2011-02-10
US20110034531A1
Human necessities

USE OF HDAC INHIBITORS FOR THE TREATMENT OF MELANOMA

#14 | 2010-07-15
US20100179208A1
Human necessities

Use of HDAC Inhibitors for the Treatment of Bone Destruction

#15 | 2010-06-03
US20100137398A1
Chemistry; metallurgy

USE OF HDAC INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL CANCERS

#16 | 2010-03-18
US20100069318A1
Human necessities

Combination of an HDAC inhibitor and an antimetabolite

#17 | 2009-11-12
US20090281159A1
Human necessities

USE OF HDAC INHIBITORS FOR THE TREATMENT OF LYMPHOMAS

#18 | 2008-08-21
US20080200489A1
Human necessities

Combination of Organic Compounds

#19 | 2007-11-08
US20070258972A1
Human necessities

Combination of a Histone Deacetylase Inhibitor with a Death Receptor Ligand

#20 | 2007-05-31
US20070123580A1
Human necessities

Combination of histone deacetylase inhibitors with chemotherapeutic agents

InventorID:

68224 ⎘